<h1>Clinical imaging CRO files provisional patent for AI system that customizes oncology Imaging Review Charters and optimizes criteria</h1> A clinical imaging CRO announced it filed a provisional patent application for an AI-enhanced system that generates customized Imaging Review Charters for oncology trials. The company claims the system integrates regulatory guidance and trial data to propose criteria clarifications and modifications, improve trial setup efficiency, and support regulatory submissions. The filing seeks to protect the technology's data-integration, customization and criteria-optimization features; any future patent prosecution will determine the scope of protection. Claims about regulatory alignment and past approval rates are commercial statements that may be relevant to diligence by sponsors, competitors, or regulators.